Skip to main content
    C

    Core Laboratories NV (CLB)

    Official site

    ENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE

    $8.46
    -0.65 (-7.13%)

    Market Cap: $417.45M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Core Laboratories NV (CLB) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Core Laboratories NV reported EPS of $0.16, below the $0.17 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    55%(22/40)
    Avg Surprise
    +4.38%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus$0.17
    Range$0.15 - $0.20
    4 analysts
    Revenue Consensus
    $134.65M
    Range$127.89M - $143.33M
    4 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus$0.13
    Range$0.13 - $0.13
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current$0.13
    Revenue Consensus
    $127.90M
    Range$127.90M - $127.90M
    1 analysts

    Next Report

    Analysts' consensus for the quarter ending Dec 31, 2026 is 19.0% below the $0.21 reported for the quarter ended Dec 31, 2025.

    CLB's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    CLB Earnings Call

    The latest CLB earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CLB beat 22, missed 8 and matched 10. Revenue for the quarter ended Sep 30, 2026 was $132.08M, down 1.8% from $134.52M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.16$0.17$0.15 - $0.17-5.88%Miss-27.3%31 up, 0 downOct 28, 2026$132.08M
    Jun 30, 2026$0.11$0.08$0.08 - $0.10+37.50%Beat-42.1%30 up, 0 downJul 29, 2026$124.61M
    Mar 31, 2026$0.06$0.11$0.06 - $0.21-45.45%Miss-57.1%31 up, 1 downApr 29, 2026$121.80M
    Dec 31, 2025$0.21$0.19$0.17 - $0.20+10.53%Beat-4.5%31 up, 0 downFeb 4, 2026$138.25M
    Sep 30, 2025$0.22$0.19$0.19 - $0.20+15.79%Beat-12.0%20 up, 1 downOct 22, 2025$134.52M
    Jun 30, 2025$0.19$0.18$0.17 - $0.18+5.56%Beat-13.6%20 up, 1 downJul 23, 2025$130.16M
    Mar 31, 2025$0.14$0.15$0.14 - $0.17-6.67%Miss-26.3%40 up, 2 downApr 23, 2025$123.58M
    Dec 31, 2024$0.22$0.22$0.19 - $0.230.00%In line+15.8%40 up, 0 downJan 29, 2025$129.24M
    Sep 30, 2024$0.25$0.23$0.17 - $0.26+8.70%Beat+13.6%60 up, 1 downOct 23, 2024$134.40M
    Jun 30, 2024$0.22$0.22$0.20 - $0.220.00%In line+4.8%71 up, 1 downJul 24, 2024$130.58M
    Mar 31, 2024$0.19$0.15$0.15 - $0.17+26.67%Beat0.0%70 up, 1 downApr 24, 2024$129.64M
    Dec 31, 2023$0.19$0.19$0.18 - $0.210.00%In line-5.0%70 up, 0 downJan 31, 2024$128.21M
    Sep 30, 2023$0.22$0.22$0.18 - $0.240.00%In line+22.2%80 up, 0 downNov 1, 2023$125.34M
    Jun 30, 2023$0.21$0.21$0.19 - $0.220.00%In line+75.0%80 up, 1 downJul 26, 2023$127.88M
    Mar 31, 2023$0.19$0.16$0.14 - $0.17+18.75%Beat+137.5%70 up, 1 downApr 26, 2023$128.36M
    Dec 31, 2022$0.20$0.19$0.18 - $0.21+5.26%Beat0.0%70 up, 0 downFeb 1, 2023$127.57M
    Sep 30, 2022$0.18$0.15$0.14 - $0.16+20.00%Beat0.0%30 up, 0 downOct 26, 2022$125.97M
    Jun 30, 2022$0.12$0.14$0.13 - $0.14-14.29%Miss-33.3%40 up, 0 downJul 27, 2022$120.90M
    Mar 31, 2022$0.08$0.06$0.06 - $0.07+33.33%Beat-46.7%40 up, 0 downApr 27, 2022$115.30M
    Dec 31, 2021$0.20$0.20N/A0.00%In line+11.1%40 up, 0 downFeb 2, 2022$125.14M
    Sep 30, 2021$0.18$0.19N/A-5.26%Miss+12.5%4N/AOct 27, 2021$117.98M
    Jun 30, 2021$0.18$0.19$0.18 - $0.21-5.26%Miss+28.6%10N/AJul 28, 2021$118.75M
    Mar 31, 2021$0.15$0.13$0.10 - $0.18+15.38%Beat-51.6%12N/AApr 21, 2021$108.38M
    Dec 31, 2020$0.18$0.16$0.10 - $0.17+12.50%Beat-52.6%12N/AJan 27, 2021$113.75M
    Sep 30, 2020$0.16$0.15$0.09 - $0.19+6.67%Beat-68.0%15N/AOct 21, 2020$105.38M
    Jun 30, 2020$0.14$0.12-$0.05 - $0.14+16.67%Beat-69.6%15N/AJul 22, 2020$115.74M
    Mar 31, 2020$0.31$0.32$0.29 - $0.38-3.13%Miss-29.5%14N/AApr 22, 2020$152.40M
    Dec 31, 2019$0.38$0.37$0.37 - $0.38+2.70%Beat-20.8%13N/AJan 29, 2020$156.78M
    Sep 30, 2019$0.50$0.49$0.48 - $0.50+2.04%Beat-21.9%14N/AOct 23, 2019$173.20M
    Jun 30, 2019$0.46$0.46$0.44 - $0.480.00%In line-22.0%14N/AJul 24, 2019$169.04M
    Mar 31, 2019$0.44$0.43$0.41 - $0.44+2.33%Beat-22.8%13N/AApr 24, 2019$169.19M
    Dec 31, 2018$0.48$0.49$0.44 - $0.53-2.04%Miss-17.2%15N/AJan 30, 2019$173.21M
    Sep 30, 2018$0.64$0.63$0.60 - $0.64+1.59%Beat+33.3%14N/AOct 24, 2018$182.15M
    Jun 30, 2018$0.59$0.59$0.58 - $0.590.00%In line+13.5%9N/AJul 25, 2018$175.47M
    Mar 31, 2018$0.57$0.57$0.55 - $0.580.00%In line+35.7%12N/AApr 25, 2018$170.02M
    Dec 31, 2017$0.58$0.58$0.56 - $0.600.00%In line+41.5%15N/AJan 31, 2018$171.85M
    Sep 30, 2017$0.48$0.44$0.44 - $0.45+9.09%Beat+26.3%17N/AOct 23, 2017$166.25M
    Jun 30, 2017$0.52$0.51$0.50 - $0.52+1.96%Beat+48.6%16N/AJul 24, 2017$163.90M
    Mar 31, 2017$0.42$0.39N/A+7.69%Beat+13.5%N/AN/AApr 19, 2017$157.81M
    Dec 31, 2016$0.41$0.40N/A+2.50%Beat-36.9%N/AN/AJan 25, 2017$149.54M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.76, down 13.6% from the year before. It was $1.51 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.76-13.6%
    Dec 31, 2024$0.88+8.6%
    Dec 31, 2023$0.81+39.7%
    Dec 31, 2022$0.58-18.3%
    Dec 31, 2021$0.71-10.1%
    Dec 31, 2020$0.79-55.6%
    Dec 31, 2019$1.78-21.9%
    Dec 31, 2018$2.28+14.0%
    Dec 31, 2017$2.00+32.5%
    Dec 31, 2016$1.51N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,000 words across 5 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,0405
    2026Q2Jun 30, 20266,7147
    2026Q1Mar 31, 20266,5606
    2025Q4Dec 31, 20257,7936
    2025Q3Sep 30, 20255,1005
    2025Q2Jun 30, 20254,9015
    2025Q1Mar 31, 20256,2076
    2024Q4Dec 31, 20246,2147

    2026Q3 Earnings Call

    Opening remarks

    Lawrence Bruno Chairman and CEO Thanks, Cindy. Good morning in the Americas, good afternoon in Europe, Africa and the Middle East, and good evening in Asia Pacific. We'd like to welcome all of our shareholders, analysts and, most importantly, our employees to Core Laboratories Third Quarter 2026 Earnings Call. This morning, I'm joined by Chris Hill, Core's Chief Financial Officer, and Gwen Gresham, Core's Senior Vice President and Head of Investor Relations. The call will be divided into 6 segments. Gwen will start by making remarks regarding forward-looking statements. We'll then have some opening comments, including a high-level review of important factors in Core's Q3 performance. In addition, we'll review Core's strategies and the 3 financial tenets that Core Lab employs to build long-term shareholder value. Chris will then give a detailed financial overview and have additional comments regarding shareholder value. Following Chris, Gwen will provide some comments on the company's outlook and guidance. I'll then review Core's 2 operating segments, detailing our progress and discussing the continued successful introduction and deployment of Core Lab's technologies, as well as highlighting some of Core's operations, recent client interactions and major projects worldwide. Then we'll open the phones for a Q&A session. I'll now turn the call over to Gwen for remarks on forward-looking statements.

    Gwendolyn Schreffler Senior Vice President and Head of Investor Relations Before we start the conference this morning, I'll mention that some of the statements that we make during this call may include projections, estimates and other forward-looking information. This would include any discussion of the company's business outlook. These types of forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to materially differ from our forward-looking statements. These risks and uncertainties are discussed in our most recent annual report on Form 10-K, as well as other reports and registration statements filed by us with the SEC. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Our comments also include non-GAAP financial measures. Reconciliation to the most directly comparable GAAP financial measures is included in the press release announcing our third quarter results. Those non-GAAP measures can also be found on our website. With that said, I'll pass the discussion back to Larry.

    Lawrence Bruno Chairman and CEO Thanks, Gwen. Moving now to some high-level comments about our third quarter 2026 results. Compared to the second quarter, operational performance improved nicely with higher revenue, operating income, operating margins and earnings per share. Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic opportunities.

    Frequently Asked Questions About CLB

    Did CLB beat earnings estimates last quarter?

    No. Core Laboratories NV reported EPS of $0.16 for the quarter ended Sep 30, 2026, below the $0.17 estimate by 5.88%.

    What EPS do analysts expect from CLB next quarter?

    The consensus EPS estimate for Core Laboratories NV for the quarter ending Dec 31, 2026 is $0.17 from 4 analysts, with estimates from $0.15 to $0.20.

    How often does CLB beat earnings estimates?

    Core Laboratories NV beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +1.42%.